Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 0.9 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.003 | 1 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0034 | 1 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |